Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge

By Sebban Catherine  

Supportive Care in Cancer, Vol. 16, Iss. 9, 2008-09 ,pp. : 1017-1023

Springer Publishing Company

Access to resources Recommend Favorite

Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection

By Klastersky Jean   Paesmans Marianne  

Supportive Care in Cancer, Vol. 15, Iss. 2, 2007-02 ,pp. : 137-141

Springer Publishing Company

Access to resources Recommend Favorite

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone

By Mizuno Toshiro   Katsumata Noriyuki   Mukai Hirofumi   Shimizu Chikako   Ando Masashi   Watanabe Toru  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 287-291

Springer Publishing Company

Access to resources Recommend Favorite

Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children

By Le Guyader N.  

Supportive Care in Cancer, Vol. 12, Iss. 10, 2004-10 ,pp. : 720-724

Springer Publishing Company

Access to resources Recommend Favorite

Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatment

By Schwenkglenks Matthias  

Supportive Care in Cancer, Vol. 14, Iss. 9, 2006-09 ,pp. : 901-909

Springer Publishing Company

Access to resources Recommend Favorite